PILL · Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Direxion Shares ETF Trust
$20.99
+0.57%
At close · Sep 4
Net assets $12,893,067
Holdings59
1 month
+1.11%
Year to date
+71.00%
52-week range
$7.06–$24.15
30-session avg volume
54,382
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000050532
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| ORGANON & COMPANY | OGN | $357,194 | 2.77% |
| CORCEPT THERAPEUTICS INC | CORT | $237,903 | 1.85% |
| ENLIVEN THERAPEUTICS INC | ELVN | $231,713 | 1.80% |
| AXSOME THERAPEUTICS INC | AXSM | $224,578 | 1.74% |
| OMEROS CORP | OMER | $211,160 | 1.64% |
| PERRIGO COMPANY PLC | PRGO | $208,242 | 1.62% |
| DEFINIUM THERAPEUTICS INC | DFTX | $202,609 | 1.57% |
| NEKTAR THERAPEUTICS | NKTR | $200,099 | 1.55% |
| TREVI THERAPEUTICS INC | TRVI | $198,846 | 1.54% |
| TERNS PHARMACEUTICALS INC | 880881107 | $195,259 | 1.51% |
| INDIVIOR PHARMACEUTICALS INC | INDV | $193,352 | 1.50% |
| PACIRA BIOSCIENCES INC | PCRX | $192,628 | 1.49% |
| HARROW INC | HROW | $189,275 | 1.47% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | $189,012 | 1.47% |
| HARMONY BIOSCIENCES HOLDINGS INC | HRMY | $187,341 | 1.45% |
| ROYALTY PHARMA PLC | RPRX | $185,083 | 1.44% |
| AMYLYX PHARMACEUTICALS INC | AMLX | $184,896 | 1.43% |
| VIATRIS INC | VTRS | $184,539 | 1.43% |
| CRINETICS PHARMACEUTICALS INC | CRNX | $180,947 | 1.40% |
| ANI PHARMACEUTICALS INC | ANIP | $179,716 | 1.39% |
| LIGAND PHARMACEUTICALS INC | LGND | $178,971 | 1.39% |
| MBX BIOSCIENCES INC | MBX | $177,271 | 1.37% |
| INNOVIVA INC | INVA | $176,908 | 1.37% |
| LIQUIDIA CORP | LQDA | $175,426 | 1.36% |
| AMNEAL PHARMACEUTICALS INC | AMRX | $174,710 | 1.36% |
| XERIS BIOPHARMA HOLDINGS INC | XERS | $174,654 | 1.35% |
| BRISTOL-MYERS SQUIBB COMPANY | BMY | $174,257 | 1.35% |
| EDGEWISE THERAPEUTICS INC | EWTX | $172,354 | 1.34% |
| OCULAR THERAPEUTIX INC | OCUL | $170,178 | 1.32% |
| PFIZER INC | PFE | $168,771 | 1.31% |
| NUVATION BIO INC | NUVB | $167,280 | 1.30% |
| ZOETIS INC | ZTS | $165,672 | 1.28% |
| ELANCO ANIMAL HEALTH INC | ELAN | $164,576 | 1.28% |
| COLLEGIUM PHARMACEUTICAL INC | COLL | $163,388 | 1.27% |
| JOHNSON & JOHNSON | JNJ | $163,194 | 1.27% |
| MERCK & COMPANY INC | MRK | $162,132 | 1.26% |
| ALUMIS INC | ALMS | $161,744 | 1.25% |
| ELI LILLY & COMPANY | LLY | $160,751 | 1.25% |
| TARSUS PHARMACEUTICALS INC | TARS | $157,053 | 1.22% |
| SUPERNUS PHARMACEUTICALS INC | SUPN | $155,616 | 1.21% |
| PHIBRO ANIMAL HEALTH CORP | PAHC | $154,807 | 1.20% |
| EYEPOINT INC | EYPT | $152,645 | 1.18% |
| PRESTIGE CONSUMER HEALTHCARE INC | PBH | $149,924 | 1.16% |
| AMPHASTAR PHARMACEUTICALS INC | AMPH | $146,122 | 1.13% |
| THERAVANCE BIOPHARMA INC | TBPH | $131,509 | 1.02% |
| PHATHOM PHARMACEUTICALS INC | PHAT | $130,581 | 1.01% |
| RAPPORT THERAPEUTICS INC | RAPP | $130,234 | 1.01% |
| ESPERION THERAPEUTICS INC | 29664W105 | $128,294 | 1.00% |
| CORMEDIX INC | CRMD | $122,958 | 0.95% |
| ARVINAS INC | ARVN | $104,762 | 0.81% |